How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
What if the next big leap in artificial intelligence wasn’t locked behind corporate walls but freely available to everyone? Enter the MiniMax M2, a new open source AI model that’s rewriting the rules ...
Aoostar released an updated teaser image of its AMD Ryzen Strix Halo-powered mini PC, the Aoostar Nex395, with a much different design than the original. The new design looks much smoother and more ...
2-Year U.S. Treasury Note Continuous Contract $104.313 0.008 0.01% 5-Year U.S. Treasury Note Continuous Contract $109.117 0.023 0.02% 10-Year U.S. Treasury Note Continuous Contract $112.219 0.047 0.04 ...
The Ryzen AI Max+ 395 is AMD’s most powerful consumer APU to date, combining 16 Zen 5 CPU cores with 32 threads and a boost clock of up to 5.1GHz. Built on TSMC’s 4nm process, this processor delivers ...
I love portable technology—if you can put it in a pocket or a bag, I’m probably into it. I’ve covered phones and tablets of all shapes and sizes, and reviewed everything from game consoles to laptops ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback